Tag: Litigation

In 1983, the popular morning sickness medication Bendectin, which contained the active ingredient doxylamine, was voluntarily removed from the market by its manufacturer, Merrell Dow Pharmaceuticals, due to financial pressures from lawsuits. This withdrawal occurred despite overwhelming scientific evidence showing no link between Bendectin and birth defects. The complex story of why was doxylamine withdrawn reveals a crucial intersection of scientific fact, public fear, and legal strategy.

Suboxone manufacturers have faced billions in financial penalties over recent years for deceptive marketing and antitrust violations. For those affected, the key question is: how much money are people getting from the Suboxone lawsuit? The answer is not straightforward and depends heavily on which specific legal action a person is part of, as payouts from past class-action settlements differ significantly from potential future compensation for dental injuries.